Significance of BPA Transporters in BNCT : Tumor–Selective Delivery, T/N Ratio, and Immunological Effects
MEMBRANE · 2026 · 51 (2) · 55-64
DOI: 10.5360/membrane.51.55 ↗Kurz gefasst
Fachartikel in der Zeitschrift MEMBRANE, 2026. Verfasst von Yoshikatsu Kanai und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Boron neutron capture therapy (BNCT) achieves cellular–scale lethality of cancer cells via the 10B(n,α)7Li reaction; hence, its clinical performance is governed by intratumoral boron delivery and the tumor–to–normal tissue (T/N) ratio. This review frames BNCT drug delivery in the context of transporter biology, focusing on L–p– boronophenylalanine (BPA). It highlights LAT1 (SLC7A5) as a pivotal determinant of tumor uptake, while underscoring a recurrent interpretive pitfall: transcript–level databases and diffuse cytoplasmic immunostaining can misrepresent in vivo transport competence, which requires 4F2hc–dependent heterodimerization and bona fide plasmamembrane localization. Evidence further indicates that BPA is not strictly LAT1–exclusive; LAT2 and ATB0,+ can contribute in a concentration– and tumor–context–dependent manner, with implications for infusion design, background uptake, and T/N optimization. Beyond pharmacokinetics, emerging data suggest that BNCT may preferentially spare tumor–infiltrating immune cells and thereby promote systemic antitumor immunity, including abscopal responses, potentially reflecting differential LAT1 expression and BPA partitioning between malignant and immune compartments. Finally, this review discusses structure-guided alternatives exemplified by BPA–containing dipeptides targeting PEPT1 (SLC15A1), whose expression landscape differs from LAT1/ATB0,+ and may complement BPA–BNCT through refined patient stratification and expanded delivery routes.
Zitieren
APA
Kanai, Y., & Xu, M. (2026). Significance of BPA Transporters in BNCT : Tumor–Selective Delivery, T/N Ratio, and Immunological Effects. MEMBRANE, 51(2), 55-64. https://doi.org/10.5360/membrane.51.55
Vancouver
Kanai Y, Xu M. Significance of BPA Transporters in BNCT : Tumor–Selective Delivery, T/N Ratio, and Immunological Effects. MEMBRANE. 2026;51(2):55-64. doi:10.5360/membrane.51.55
BibTeX
@article{Kanai2026,
author = {Kanai, Yoshikatsu and Xu, Minhui},
title = {Significance of BPA Transporters in BNCT : Tumor–Selective Delivery, T/N Ratio, and Immunological Effects},
journal = {MEMBRANE},
year = {2026},
volume = {51},
number = {2},
pages = {55--64},
doi = {10.5360/membrane.51.55}
}
EUVIMED